The treatment of HCC also resulted in decreases in SLC45A2–AMACR and ZMPSTE24–ZMYM4 in 92.1% and 86.8% of the patients with HCC, respectively. The gene discussed is SLC45A2; the disease is hepatocellular carcinoma.